abrdn Healthcare Investors

Last updated September 27, 2026

Organization details

7 of this board's directors also sit on 12 other boards.

Shared director Other board Same sector

abrdn Life Sciences Investors
via Bill Maher, Chris LaVictoire Mahai, Daniel R. Omstead, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
abrdn Healthcare Opportunities Fund
via Bill Maher, Chris LaVictoire Mahai, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
abrdn World Healthcare Fund
via Bill Maher, Chris LaVictoire Mahai, Kathleen Goetz, Rose DiMartino, Stephen Bird and Todd Reit
Aberdeen Multi-Market Income Fund
via Bill Maher and Todd Reit
Aberdeen Municipal Income Fund
via Bill Maher and Todd Reit
Aurinia Pharmaceuticals Inc
via Kathleen Goetz
abrdn Emerging Markets ex-China Fund Inc.
via Bill Maher
abrdn Global Dynamic Dividend Fund
via Todd Reit
abrdn Global Infrastructure Income Fund
via Chris LaVictoire Mahai
abrdn Global Premier Properties Fund
via Todd Reit
abrdn Income Credit Strategies Fund
via Todd Reit
abrdn Total Dynamic Dividend Fund
via Todd Reit

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date	Insider	Transaction	Shares	Price	Value
Jul 16, 2024	Rose DiMartino Director	Open-market purchase	+1,000	$18.88	$18,880
Apr 9, 2024	Kathleen Goetz Director	Open-market purchase	+525	$16.42	$8,621
Jan 2, 2024	Todd Reit Director	Open-market purchase	+1,000	$16.93	$16,930
Dec 28, 2023	Bill Maher Director	Open-market purchase	+1,000	$16.58	$16,580
Dec 21, 2023	Goodson Alan R Officer (Vice President)	Open-market purchase	+170	$16.13	$2,742
Sep 25, 2023	Daniel R. Omstead Director, Officer (President)	Open-market purchase	+9,500	$15.63	$148,485
Sep 20, 2023	Daniel R. Omstead Director, Officer (President)	Open-market purchase	+9,500	$15.88	$150,860

No reviews yet. Be the first to write one.